Evidence map›Paper›PMID 39258852›Full record

ArticleEmerging microbes & infections2024

Emergence and transmission of the high-risk ST78 clone of OXA-48-producing

Chih-Ming Chen, Hui-Ling Tang, Ying-Tsong Chen, Se-Chin Ke, Yi-Pei Lin, Bo-Han Chen, Ru-Hsiou Teng, Chien-Shun Chiou, Min-Chi Lu, Yi-Chyi Lai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging microbes & infections, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. High-risk clonal expansion of IMP-producingAntimicrobial agents and chemotherapy · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chih-Ming ChenDepartment of Internal Medicine, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan.
Hui-Ling TangDepartment of Microbiology and Immunology, School of Medicine, China Medical University, Taichung, Taiwan.
Ying-Tsong ChenInstitute of Genomics and Bioinformatics, National Chung Hsing University, Taichung, Taiwan.
Se-Chin KeInfection Control Office, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan.
Yi-Pei LinDepartment of Medical Research, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan.
Bo-Han ChenCentral Region Laboratory, Center for Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan.
Ru-Hsiou TengCentral Region Laboratory, Center for Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan.
Chien-Shun ChiouCentral Region Laboratory, Center for Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan.
Min-Chi LuDepartment of Microbiology and Immunology, School of Medicine, China Medical University, Taichung, Taiwan.
Yi-Chyi LaiDepartment of Microbiology and Immunology, School of Medicine, Chung Shan Medical University, Taichung, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant

Indexed as

Bacterial Proteinsbeta-LactamasesEnterobacterEnterobacteriaceae InfectionsPlasmidsAnti-Bacterial AgentsCarbapenem-Resistant EnterobacteriaceaeHospitalsHumansMicrobial Sensitivity TestsTaiwanAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseoxacillinaseCarbapenemase genesEnterobacter hormaecheimcr-9.1OXA-48plasmidomeresistomeST78

Identifiers

PMID39258852
PMCPMC11421146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.